Patent details

EP2624859 Title: FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY

Basic Information

Publication number:
EP2624859
PCT Application Number:
EP2011066241
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP117610519
PCT Publication Number:
WO2012045569
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY
French Title of Invention:
FACTEUR II SEUL OU EN COMBINAISON AVEC D'AUTRES FACTEURS POUR LE TRAITEMENT DE L'HÉMOSTASE ALTÉRÉE LORS DE LA COAGULOPATHIE DE DILUTION
German Title of Invention:
FAKTOR II ALLEINE ODER MIT ANDEREN FAKTOREN ZUR BEHANDLUNG VON GESTÖRTER HÄMOSTASE IN DER DILUTIONALEN BLUTGERINNUNGSSTÖRUNG
SPC Number:

Dates

Filing date:
19/09/2011
Grant date:
01/03/2017
EP Publication Date:
14/08/2013
PCT Publication Date:
12/04/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/03/2017
EP B1 Publication Date:
01/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/09/2017
Expiration date:
19/09/2031
Renunciation date:
Revocation date:
18/07/2020
Annulment date:

Owner

From:
01/03/2017
 
 

Name:
Medimmune Limited
Address:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, United Kingdom (GB)

Inventor

1

Name:
LOVGREN, Ann
Address:
Sweden (SE)

2

Name:
HANSSON, Kenny
Address:
Sweden (SE)

Priority

Priority Number:
390224 P
Priority Date:
06/10/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/36; A61K 38/48; A61P 7/04;

Publication

European Patent Bulletin

1

Issue number:
201709
Publication date:
01/03/2017
Description:
Grant (B1)

2

Issue number:
202048
Publication date:
25/11/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/01/2018 Outgoing Correspondence 1